Cargando…
Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancer
Primary prostate cancer (PC) progresses to castration-resistant PC (CRPC) under androgen deprivation therapy, by mechanisms e.g. expression of androgen receptor (AR) splice variant-7 (AR-V7). Here we conducted comprehensive epigenome and transcriptome analyses comparing LNCaP, primary PC cells, and...
Autores principales: | Sugiura, Masahiro, Sato, Hiroaki, Okabe, Atsushi, Fukuyo, Masaki, Mano, Yasunobu, Shinohara, Ken-ichi, Rahmutulla, Bahityar, Higuchi, Kosuke, Maimaiti, Maihulan, Kanesaka, Manato, Imamura, Yusuke, Furihata, Tomomi, Sakamoto, Shinichi, Komiya, Akira, Anzai, Naohiko, Kanai, Yoshikatsu, Luo, Jun, Ichikawa, Tomohiko, Kaneda, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581977/ https://www.ncbi.nlm.nih.gov/pubmed/33096335 http://dx.doi.org/10.1016/j.tranon.2020.100915 |
Ejemplares similares
-
Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancer
por: Wüstmann, Neele, et al.
Publicado: (2023) -
Huaier Extract Inhibits Prostate Cancer Growth via Targeting AR/AR-V7 Pathway
por: Liu, Zhengfang, et al.
Publicado: (2021) -
Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases
por: Kallio, Heini M. L., et al.
Publicado: (2018) -
Detection of androgen receptor (AR) and AR-V7 in small cell prostate carcinoma: Diagnostic and therapeutic implications
por: Zhao, Pei, et al.
Publicado: (2019) -
AR Splicing Variants and Resistance to AR Targeting Agents
por: Kanayama, Mayuko, et al.
Publicado: (2021)